[HTML][HTML] Herpes simplex virus 1 (HSV-1) reactivation in critically ill COVID-19 patients: A brief narrative review

DR Giacobbe, S Di Bella, A Lovecchio, L Ball… - Infectious Diseases and …, 2022 - Springer
Systemic or pulmonary reactivations of herpes simplex virus 1 (HSV-1) have been reported
in critically ill patients with COVID-19, posing a dilemma for clinicians in terms of their …

Pattern-recognition receptors (PRRs) in SARS-CoV-2

A Isazadeh, JA Heris, P Shahabi, R Mohammadinasab… - Life Sciences, 2023 - Elsevier
Pattern recognition receptors (PRRs) are specific sensors that directly recognize various
molecules derived from viral or bacterial pathogens, senescent cells, damaged cells, and …

Lessons from SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 Infections: What We Know So Far

RT Alsafi - Canadian Journal of Infectious Diseases and …, 2022 - Wiley Online Library
Within past decades, human infections with emerging and reemerging zoonotic viral
pathogens have raised the eminent public health concern. Since November 2002, three …

[HTML][HTML] Human metapneumovirus prevalence during 2019-2021 in Israel is influenced by the COVID-19 pandemic

M Stein, H Cohen, I Nemet, N Atari, L Kliker… - International Journal of …, 2022 - Elsevier
Objectives To compare infection rates and circulating subtypes of human metapneumovirus
(hMPV) before (2019-2020) and after the emergence of coronavirus disease 2019 (COVID …

[HTML][HTML] Multi-level biological network analysis and drug repurposing based on leukocyte transcriptomics in severe COVID-19: in silico systems biology to precision …

P Sagulkoo, H Chuntakaruk, T Rungrotmongkol… - Journal of personalized …, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic causes many morbidity and mortality
cases. Despite several developed vaccines and antiviral therapies, some patients …

Inhibitors of SARS-CoV-2 main protease: Biological efficacy and toxicity aspects

J Viskupicova, P Rezbarikova, L Kovacikova… - Toxicology in Vitro, 2023 - Elsevier
The emergence of the highly contagious respiratory disease, COVID-19, caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a significant …

[HTML][HTML] Assessing T-cell immunity in kidney transplant recipients with absent antibody production after a 3rd dose of the mRNA-1273 vaccine

M Infantino, A Tsalouchos, E Russo… - International Journal of …, 2022 - mdpi.com
The vulnerable population of kidney transplant recipients (KTRs) are low responders to
COVID-19 vaccines, so specific immune surveillance is needed. The interferon-gamma (IFN …

[HTML][HTML] The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm—A Powerful Therapeutic Tool for COVID-19 Patients

M Csobonyeiova, V Smolinska, S Harsanyi… - Biomedicines, 2023 - mdpi.com
Currently, there is still no effective and definitive cure for the coronavirus disease 2019
(COVID-19) caused by the infection of the novel highly contagious severe acute respiratory …

[HTML][HTML] A systematic two-sample and bidirectional MR process highlights a unidirectional genetic causal effect of allergic diseases on COVID-19 infection/severity

X Chen, S Zhi, X Han, J Jiang, G Liu, S Rao - Journal of Translational …, 2024 - Springer
Abstract Background Allergic diseases (ADs) such as asthma are presumed risk factors for
COVID-19 infection. However, recent observational studies suggest that the assumed …

[HTML][HTML] Potential role of colchicine in combating COVID-19 cytokine storm and its ability to inhibit protease enzyme of SARS-CoV-2 as conferred by molecular docking …

NA Kamel, NSM Ismail, IS Yahia, KM Aboshanab - Medicina, 2021 - mdpi.com
Despite the advance in the management of Coronavirus disease 2019 (COVID-19), the
global pandemic is still ongoing with a massive health crisis. COVID-19 manifestations may …